Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abnormal periocular vasculature" refers to atypical or malformed blood vessels in the tissues surrounding the eye. This is not a specific molecule, receptor, or canonical therapeutic target; rather, it describes a clinical finding that may result from various underlying conditions such as congenital vascular malformations (e.g., capillary, venous, lymphatic, arteriovenous), acquired diseases like diabetes or hypertension affecting ocular circulation, or syndromic associations[2][3][5][7]. These abnormalities can manifest as visible vessel dilation, tortuosity, beading (as seen in diabetic retinopathy), swelling due to lymphatic involvement, bleeding risk from fragile vessels, and cosmetic deformities[2][5][7]. Diagnosis typically relies on clinical examination and imaging. Management depends on the underlying cause and may involve observation for benign cases or interventions such as laser therapy or embolization for symptomatic lesions[2][3]. This entry is considered incorrect for use as a molecular drug target because it does not represent an individual protein/receptor/enzyme/transporter but rather an anatomical/clinical phenomenon.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abnormal periocular vasculature.